Raplixa
Active substance: human fibrinogen, human thrombin
human fibrinogen, human thrombin
Centralised EU authorisationWithdrawn
Marketing holder: Mallinckrodt Pharmaceuticals Ireland Limited
Verified 2026-10-09 · EMA
- Source: EMA
- Countries with the substance registered: 1
Composition
- human fibrinogen
- human thrombin
Registration
- Registration number
- EMEA/H/C/002807
- Registration status
- Withdrawn
- ATC code
- B02BC30
Sources
- product · EMA · EMEA/H/C/002807 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002807 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002807 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/002807 · Verified 2026-10-09